Compare ORIC & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | WDI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 715.3M |
| IPO Year | 2020 | N/A |
| Metric | ORIC | WDI |
|---|---|---|
| Price | $13.46 | $12.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $19.73 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 213.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ 1.12 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $12.91 |
| 52 Week High | $14.93 | $15.28 |
| Indicator | ORIC | WDI |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 26.52 |
| Support Level | $10.17 | N/A |
| Resistance Level | $13.97 | $13.80 |
| Average True Range (ATR) | 0.69 | 0.12 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 54.24 | 4.55 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Western Asset Diversified Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund will seek capital appreciation. The fund seeks to achieve its investment objectives by investing, under normal market conditions, across fixed income sectors and securities in seeking to deliver a well-diversified portfolio.